Year archive

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. — 2023 filings

All 51 regulatory filings released by Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2315) in 2023, sourced directly from the official regulator.

51 Filings

2023 Period

2023 filings (51)

Filing	Released	Lang
VOLUNTARY ANNOUNCEMENT BIOCYTOGEN ENTERED INTO MULTI-TARGET ANTIBODY AGREEMENT WITH NEUROCRINE BIOSCIENCES Regulatory Filings	2023-12-20	English
VOLUNTARY ANNOUNCEMENT BIOCYTOGEN ENTERS INTO ANTIBODY AGREEMENT WITH ONA THERAPEUTICS TO DEVELOP ANTIBODY-DRUG CONJUGATES TARGETING SOLID TUMORS Regulatory Filings	2023-12-18	English
Articles of Association Governance Information	2023-12-12	English
POLL RESULTS OF THE 2023 SECOND EXTRAORDINARY GENERAL MEETING THE 2023 SECOND CLASS MEETING OF H SHAREHOLDERS AND THE 2023 SECOND CLASS MEETING OF DOMESTIC AND UNLISTED SHAREHOLDERS HELD ON DECEMBER 1 Declaration of Voting Results & Voting Rights Announcements	2023-12-12	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023 Regulatory Filings	2023-12-05	English
BIOCYTOGEN SECURES U.S. PATENT FOR THE KEY TECHNOLOGY OF FULLY HUMAN ANTIBODY MICE RENMAB Regulatory Filings	2023-12-05	English
FORM OF PROXY FOR THE USE AT 2023 SECOND CLASS MEETING OF DOMESTIC AND UNLISTED SHAREHOLDERS TO BE HELD ON DECEMBER 12, 2023 Proxy Solicitation & Information Statement	2023-11-22	English
FORM OF PROXY FOR THE USE AT 2023 SECOND CLASS MEETING OF H SHAREHOLDERS TO BE HELD ON DECEMBER 12, 2023 Proxy Solicitation & Information Statement	2023-11-22	English
FORM OF PROXY FOR THE USE AT THE 2023 SECOND EXTRAORDINARY GENERAL MEETING TO BE HELD ON DECEMBER 12, 2023 Proxy Solicitation & Information Statement	2023-11-22	English
NOTICE OF THE 2023 SECOND CLASS MEETING OF DOMESTIC AND UNLISTED SHAREHOLDERS Proxy Solicitation & Information Statement	2023-11-22	English
NOTICE OF THE 2023 SECOND CLASS MEETING OF H SHAREHOLDERS Proxy Solicitation & Information Statement	2023-11-22	English
NOTICE OF THE 2023 SECOND EXTRAORDINARY GENERAL MEETING Regulatory Filings	2023-11-22	English
(1) PROPOSED AMENDMENTS TO THE ARTICLES AND RULES OF PROCEDURES (2) PROPOSED AMENDMENTS TO THE ARTICLES AND RULES OF PROCEDURES ANCILLARY TO THE PROPOSED ISSUE OF A SHARES (3) PROPOSED GUARANTEE FOR S Proxy Solicitation & Information Statement	2023-11-22	English
(1) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION (2) PROPOSED ELECTION OF MEMBERS OF THE SECOND SESSION OF THE BOARD OF DIRECTORS AND NON-EMPLOYEE REPRESENTATIVE SUPERVISORS Board/Management Information	2023-11-10	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023 Regulatory Filings	2023-11-03	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023 Regulatory Filings	2023-10-06	English
2023 Interim Report Interim / Quarterly Report H1 2023	2023-09-26	English
VOLUNTARY ANNOUNCEMENT RENMICE SERIES-FULLY HUMAN ANTIBODY AND TCR MOUSE MODELS-SHOWCASE BIOCYTOGEN'S CAPABILITIES TO INNOVATE THE DISCOVERY OF BIOLOGIC DRUGS Regulatory Filings	2023-09-14	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2023 Regulatory Filings	2023-09-06	English
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2023 Interim / Quarterly Report H1 2023	2023-08-28	English
DATE OF BOARD MEETING Regulatory Filings	2023-08-14	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023 Regulatory Filings	2023-08-04	English
VOLUNTARY ANNOUNCEMENT THE KEY TECHNOLOGY OF BIOCYTOGEN'S FULLY HUMAN ANTIBODY RENMAB PLATFORM HAS BEEN GRANTED A CHINESE PATENT Regulatory Filings	2023-07-11	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2023 Regulatory Filings	2023-07-06	English
ANNOUNCEMENT ACCEPTANCE BY THE SHANGHAI STOCK EXCHANGE OF APPLICATION MATERIALS FOR THE PROPOSED ISSUE OF A SHARES Capital/Financing Update	2023-06-20	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2023 Regulatory Filings	2023-06-06	English
POLL RESULTS OF THE 2022 ANNUAL GENERAL MEETING HELD ON MAY 25, 2023 Declaration of Voting Results & Voting Rights Announcements	2023-05-25	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2023 Regulatory Filings	2023-05-05	English
FORM OF PROXY FOR THE USE AT THE 2022 ANNUAL GENERAL MEETING AGM Information	2023-05-02	English
(1)ANNUAL REPORT FOR 2022 (2)THE BOARD OF DIRECTORS WORK REPORT (3)THE SUPERVISORY COMMITTEE WORK REPORT (4)FINAL ACCOUNTS REPORT (5)PROPOSED RE-APPOINTMENT OF THE AUDITOR (6)PROPOSED REMUNERATION OF AGM Information	2023-05-02	English
NOTICE OF THE 2022 ANNUAL GENERAL MEETING AGM Information	2023-05-02	English
ANNUAL REPORT 2022 Annual Report FY 2022	2023-04-26	English
POLL RESULTS OF THE 2023 FIRST EXTRAORDINARY GENERAL MEETING, THE 2023 FIRST CLASS MEETING OF H SHAREHOLDERS AND THE 2023 FIRST CLASS MEETING OF DOMESTIC AND UNLISTED SHAREHOLDERS HELD ON 20 APRIL 202 Declaration of Voting Results & Voting Rights Announcements	2023-04-21	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2023 Regulatory Filings	2023-04-11	English
FORM OF PROXY FOR THE USE AT THE 2023 FIRST CLASS MEETING OF DOMESTIC AND UNLISTED SHAREHOLDERS HELD ON 20 APRIL 2023 Proxy Solicitation & Information Statement	2023-03-30	English
FORM OF PROXY FOR THE USE AT THE 2023 FIRST CLASS MEETING OF H SHAREHOLDERS HELD ON 20 APRIL 2023 Proxy Solicitation & Information Statement	2023-03-30	English
FORM OF PROXY FOR THE USE AT THE 2023 FIRST EXTRAORDINARY GENERAL MEETING HELD ON 20 APRIL 2023 Proxy Solicitation & Information Statement	2023-03-30	English
NOTICE OF THE 2023 FIRST CLASS MEETING OF DOMESTIC AND UNLISTED SHAREHOLDERS Proxy Solicitation & Information Statement	2023-03-30	English
NOTICE OF THE 2023 FIRST CLASS MEETING OF H SHAREHOLDERS Regulatory Filings	2023-03-30	English
NOTICE OF THE 2023 FIRST EXTRAORDINARY GENERAL MEETING Proxy Solicitation & Information Statement	2023-03-30	English
(1) PROPOSED ISSUE OF A SHARES UNDER SPECIFIC MANDATE AND LISTING ON THE SCI-TECH BOARD AND OTHER ANCILLARY RESOLUTIONS (2) PROPOSED AMENDMENTS TO THE ARTICLES ANCILLARY TO THE PROPOSED ISSUE (3) PROP Proxy Solicitation & Information Statement	2023-03-30	English
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2022 Annual Report FY 2022	2023-03-27	English
SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO PROPOSED ISSUE OF A SHARES UNDER SPECIFIC MANDATE AND LISTING ON THE SCI-TECH BOARD AND OTHER ANCILLARY RESOLUTIONS Capital/Financing Update	2023-03-15	English
DATE OF BOARD MEETING Report Publication Announcement	2023-03-15	English
VOLUNTARY ANNOUNCEMENT ENTERING INTO RENLITE LICENSING AGREEMENT WITH JANSSEN Regulatory Filings	2023-03-08	English
(1) PROPOSED ISSUE OF A SHARES UNDER SPECIFIC MANDATE AND LISTING ON THE SCI-TECH BOARD AND OTHER ANCILLARY RESOLUTIONS AND (2) PROPOSED AMENDMENTS TO THE ARTICLES ANCILLARY TO THE PROPOSED ISSUE Capital/Financing Update	2023-03-06	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2023 Regulatory Filings	2023-03-06	English
VOLUNTARY ANNOUNCEMENT ENTERING INTO GREATER CHINA LICENSE AGREEMENT WITH CHIPSCREEN BIOSCIENCES' HOLDING SUBSIDIARY CHIPSCREEN NEWWAY BIOSCIENCES FOR YH008 BISPECIFIC ANTIBODY Capital/Financing Update	2023-02-27	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2023-02-17	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2023 Regulatory Filings	2023-02-06	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2022 Share Issue/Capital Change	2023-01-05	English